Literature DB >> 31569215

Cases in Precision Medicine: Should You Participate in a Study Involving Genomic Sequencing of Your Patients?

Paul S Appelbaum1, Deborah F Stiles2, Wendy Chung3.   

Abstract

Internists and other physicians may be asked to participate in research studies that include genomic screening of their patients. Because genomic studies can identify many variants with potential clinical or personal implications, physicians should carefully consider the effect of participation on their patients, as well as the time and effort needed for the physicians to interpret the results and decide how best to use the information. Among the questions they will need to explore is whether testing will be done in a laboratory that is certified under the Clinical Laboratory Improvement Amendments and authorized to generate results for clinical purposes. Physicians should also determine which results will be returned and how these results are likely to affect their patients. Consent must be obtained from patients for return of results, and physicians may want to use the various informational tools that are available to help their patients through the process of deciding which results to receive. Given the complexity of genomic results, including variable penetrance and possible preventive interventions, the research study should support physicians in understanding the results and their implications for patients. Physicians should be prepared to communicate results in a manner that facilitates patients' understanding of the findings and their implications, using a communication process tailored to the needs of the individual patient. Engaging genetic counselors in helping patients understand the implications of genomic findings can be helpful because of their scientific understanding of genetic disorders, experience in dealing with patients, and training in counseling skills.

Entities:  

Mesh:

Year:  2019        PMID: 31569215      PMCID: PMC7108960          DOI: 10.7326/M19-1414

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Finding the Rare Pathogenic Variants in a Human Genome.

Authors:  James P Evans; Bradford C Powell; Jonathan S Berg
Journal:  JAMA       Date:  2017-05-09       Impact factor: 56.272

2.  Return of Research Results to Study Participants: Uncharted and Untested.

Authors:  Charlene A Wong; Adrian F Hernandez; Robert M Califf
Journal:  JAMA       Date:  2018-08-07       Impact factor: 56.272

3.  The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations.

Authors:  Gail E Henderson; Susan M Wolf; Kristine J Kuczynski; Steven Joffe; Richard R Sharp; D Williams Parsons; Bartha M Knoppers; Joon-Ho Yu; Paul S Appelbaum
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

4.  Impact of Receiving Secondary Results from Genomic Research: A 12-Month Longitudinal Study.

Authors:  Julia Wynn; Josue Martinez; Jessica Bulafka; Jimmy Duong; Yuan Zhang; Codruta Chiuzan; Jain Preti; Maria L Cremona; Vaidehi Jobanputra; Abby J Fyer; Robert L Klitzman; Paul S Appelbaum; Wendy K Chung
Journal:  J Genet Couns       Date:  2017-11-22       Impact factor: 2.537

5.  Models of consent to return of incidental findings in genomic research.

Authors:  Paul S Appelbaum; Erik Parens; Cameron R Waldman; Robert Klitzman; Abby Fyer; Josue Martinez; W Nicholson Price; Wendy K Chung
Journal:  Hastings Cent Rep       Date:  2014-06-11       Impact factor: 2.683

6.  Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time.

Authors:  Jonathan S Berg; Muin J Khoury; James P Evans
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

7.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

8.  Clinical providers' experiences with returning results from genomic sequencing: an interview study.

Authors:  Julia Wynn; Katie Lewis; Laura M Amendola; Barbara A Bernhardt; Sawona Biswas; Manasi Joshi; Carmit McMullen; Sarah Scollon
Journal:  BMC Med Genomics       Date:  2018-05-08       Impact factor: 3.063

9.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

Review 10.  Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.

Authors:  Jonathan S Berg; Laura M Amendola; Christine Eng; Eliezer Van Allen; Stacy W Gray; Nikhil Wagle; Heidi L Rehm; Elizabeth T DeChene; Matthew C Dulik; Fuki M Hisama; Wylie Burke; Nancy B Spinner; Levi Garraway; Robert C Green; Sharon Plon; James P Evans; Gail P Jarvik
Journal:  Genet Med       Date:  2013-10-24       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.